A novel syndrome of radiation-associated acute myeloid leukemia involving AML1 gene translocations

Blood

Volumn 95, Issue 12, 2000, Pages 4011-4013

  Hromas, Robert ^a   Shopnick, Rinah ^b   Jumean, Hani George ^b   Bowers, Charles ^b   Varella Garcia, Marileila ^b   Richkind, Kathleen ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CASE REPORT; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE TRANSLOCATION; HEMATOPOIESIS; HUMAN; MALE; MYELOID LEUKEMIA; PANCYTOPENIA; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RADIATION EXPOSURE; WAR;

EID: 0034660204     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.12.4011     Document Type: Article

References (15)

1. Austin H, Delzell E, Cole P. Benzene and leukemia: a review of the literature and a risk assessment. Am J Epidemiol. 1988;127:419.
2. Brandt L, Nilsson PG, Mitelman F. Occupational exposure to petroleum products in men with acute non-lymphocytic leukaemia. Br Med J. 1978;4:553.
3. Kaldor JM, Day NE, Band P, et al. Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries. Int J Cancer. 1987;39:571.
4. Thirman MJ, Larson RA. Therapy-related myeloid leukemia. Hematol Oncol Clin North Am. 1996; 10:293.
5. Bizzozero OJ Jr, Johnson KG, Ciocco A. Radiation-related leukemia in Hiroshima and Nagasaki, 1946-1964: I, distribution, incidence and appearance time. N Engl J Med. 1986;274:1095.
6. Ishimaru T, Otake M, Ischimaru M. Dose-response relationship of neutrons and gamma rays to leukemia incidence among atomic bomb survivors in Hiroshima and Nagasaki by type of leukemia, 1950-1971. Radiat Res. 1979;77:377.
7. Gluzman DF, Abramenko IV, Sklyarenko LM, et al. Acute leukemias in children from the city of Kiev and Kiev region after the Chernobyl NPP catastrophe. Pediatr Hematol Oncol.1999;16: 355.
8. Kamada N, Tanaka K, Oguma N, Mabuchi K. Cytogenetic and molecular changes in leukemia found among atomic bomb survivors. J Radiat Res (Tokyo). 1991;32 Suppl:172.
9. Paskulin GA, Philips G, Sandberg A, et al. Preclinical evaluation of probes to detect (8;21) AML minimal residual disease by fluorescence in situ hybridization. Genes Chromosomes Cancer. 1998;21:144.
10. Van der Reiden BA, Bloomfield CD, Touw IP, Jansen JH. Acute leukemias with structurally altered core binding factor subunits (t(8;21), inv(16), t(12;21) meeting report. Leukemia. 1997; 11:2217.
11. Tenen DG, Hromas R, Licht JD, Zhang DE. Transcription factors, normal myeloid development, and leukemia. Blood. 1997;90:489.
12. Nucifora G, Rowley JD. AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia. Blood. 1995;86:1.
13. Roulston D, Espinosa R, Nucifora G, Larson RA, Le Beau MM, Rowley JD. CBFA2 (AML1) translocations with novel partner chromosomes in myeloid leukemia: association with prior therapy. Blood. 1998;92:2878.
14. Deininger MW, Bose S, Gora-Tybor J, Yan XH, Goldman JM, Melo JV. Selective induction of leukemia-associated fusion genes by high-dose ionizing radiation. Cancer Res. 1998;58:421.
15. Ishihara T, Kohno S, Minamihisamatsu M. Radiation exposure and chromosome abnormalities: human cytogenetic studies at the National Institute of Radiological Sciences, Japan, 1963-1988. Cancer Genet Cytogenet. 1990;45:13.